The changing epidemiology of gout


Gout is one of the most common inflammatory arthritides, which is considered to be a true crystal deposition disorder caused by the formation of monosodium urate crystals in and around joints. A number of epidemiological studies from a diverse range of countries suggest that gout has increased in prevalence and incidence in recent years and that the clinical pattern of gout is becoming more complex. In particular, the greatest increase has been observed in primary gout in older men. Robust epidemiological studies have established risk factors for gout including genetic factors, excess alcohol consumption, purine-rich diet, the metabolic syndrome (obesity, hypertension, hyperlipidemia and insulin resistance), use of diuretics and chronic renal failure. Trends in alcohol use, diet, obesity and the metabolic syndrome in the general population might explain changes in the prevalence and incidence of gout in the community. Osteoarthritis, which is thought to predispose patients to monosodium urate crystal deposition in their joints, is becoming more prevalent as a consequence of increased longevity. In hospital settings, widespread diuretic use, increasing prevalence of end-stage renal failure and the success of organ transplant programmes have led to an increase in clinical complexity. Suboptimal management of gout is likely to have contributed to the rise in the prevalence of clinically overt, symptomatic, chronic gout.

Key Points

  • The prevalence and incidence of gout have increased in recent years

  • The most marked increase has been seen in primary gout in older men

  • Risk factors for gout include genetic factors, excess alcohol consumption, purine-rich diet, the metabolic syndrome, diuretic use, chronic renal failure and osteoarthritis

  • Trends in the epidemiology of these risk factors might explain changes in the prevalence and incidence of gout

  • Suboptimal management is a significant contributor to the rise in the prevalence of clinically overt, symptomatic, chronic gout

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Prevalence of gout in US men, 1990–1999 (adapted, with permission, from Wallace et al. 2004)3
Figure 2: Prevalence of gout in men in New Zealand
Figure 3: Incidence of gout in men and women in the UK, 1990–1999 (adapted, with permission, from Mikuls et al. 2005)13
Figure 4: Simplified diagram of uric acid production and excretion


  1. 1

    Choi HK et al. (2005) Pathogenesis of gout. Ann Intern Med 143: 499–516

    CAS  Article  Google Scholar 

  2. 2

    Nriagu JO (1983) Saturnine gout among Roman aristocrats. Did lead poisoning contribute to the fall of the Empire? N Engl J Med 308: 660–663

    CAS  Article  Google Scholar 

  3. 3

    Wallace KL et al. (2004) Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 31: 1582–1587

    PubMed  Google Scholar 

  4. 4

    Arromdee E et al. (2002) Epidemiology of gout: is the incidence rising? J Rheumatol 29: 2403–2406

    PubMed  Google Scholar 

  5. 5

    Lennane GA et al. (1960) Gout in the Maori. Ann Rheum Dis 19: 120–125

    CAS  Article  Google Scholar 

  6. 6

    Prior IA and Rose BS (1966) Uric acid, gout and public health in the South Pacific. N Z Med J 65: 295–300

    CAS  PubMed  Google Scholar 

  7. 7

    Klemp P et al. (1997) Gout is on the increase in New Zealand. Ann Rheum Dis 56: 22–26

    CAS  Article  Google Scholar 

  8. 8

    Chen SY et al. (2003) Trends in the manifestations of gout in Taiwan. Rheumatology (Oxford) 42: 1529–1533

    Article  Google Scholar 

  9. 9

    Yu KH and Luo SF (2003) Younger age of onset of gout in Taiwan. Rheumatology (Oxford) 42: 166–170

    Article  Google Scholar 

  10. 10

    Currie WJ (1979) Prevalence and incidence of the diagnosis of gout in Great Britain. Ann Rheum Dis 38: 101–106

    CAS  Article  Google Scholar 

  11. 11

    Steven MM (1992) Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis 51: 186–194

    CAS  Article  Google Scholar 

  12. 12

    Harris CM et al. (1995) The prevalence and prophylaxis of gout in England. J Clin Epidemiol 48: 1153–1158

    CAS  Article  Google Scholar 

  13. 13

    Mikuls TR et al. (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis 64: 267–272

    CAS  Article  Google Scholar 

  14. 14

    Wolfe F and Cathey MA (1991) The misdiagnosis of gout and hyperuricemia. J Rheumatol 18: 1232–1234

    CAS  PubMed  Google Scholar 

  15. 15

    Wallace SL et al. (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20: 895–900

    CAS  Article  Google Scholar 

  16. 16

    Campion EW et al. (1987) Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 82: 421–426

    CAS  Article  Google Scholar 

  17. 17

    Lin KC et al. (2000) The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J Rheumatol 27: 1501–1505

    CAS  PubMed  Google Scholar 

  18. 18

    Rieselbach RE and Steele TH (1974) Influence of the kidney upon urate homeostasis in health and disease. Am J Med 56: 665–675

    CAS  Article  Google Scholar 

  19. 19

    Zhang W et al. (2006) EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65: 1312–1324

    CAS  Article  Google Scholar 

  20. 20

    Li-Yu J et al. (2001) Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 28: 577–580

    CAS  Google Scholar 

  21. 21

    Perez-Ruiz F et al. (2002) Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Care Res 47: 356–360

    CAS  Article  Google Scholar 

  22. 22

    Scott JT and Pollard AC (1970) Uric acid excretion in the relatives of patients with gout. Ann Rheum Dis 29: 397–400

    CAS  Article  Google Scholar 

  23. 23

    Emmerson BT et al. (1992) Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 51: 375–377

    CAS  Article  Google Scholar 

  24. 24

    Wang WH et al. (2004) Complex segregation and linkage analysis of familial gout in Taiwanese aborigines. Arthritis Rheum 50: 242–246

    CAS  Article  Google Scholar 

  25. 25

    Cheng LS et al. (2004) Genomewide scan for gout in Taiwanese aborigines reveals linkage to chromosome 4q25. Am J Hum Genetics 75: 498–503

    CAS  Article  Google Scholar 

  26. 26

    Huang CM et al. (2006) Correlation of oestrogen receptor gene polymorphism with gouty arthritis. Ann Rheum Dis 65: 1673–1674

    CAS  Article  Google Scholar 

  27. 27

    Taniguchi A et al. (2005) A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. Arthritis Rheum 52: 2576–2577

    CAS  Article  Google Scholar 

  28. 28

    Choi HK et al. (2004) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363: 1277–1281

    Article  Google Scholar 

  29. 29

    Choi HK et al. (2004) Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 350: 1093–1103

    CAS  Article  Google Scholar 

  30. 30

    Puig JG and Fox IH (1984) Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate. J Clin Invest 74: 936–941

    CAS  Article  Google Scholar 

  31. 31

    Yu TF et al. (1957) Effect of sodium lactate infusion on urate clearance in man. Proc Soc Exp Biol Med 96: 809–813

    CAS  Article  Google Scholar 

  32. 32

    Lieber CS et al. (1962) Interrelation of uric acid and ethanol metabolism in man. J Clin Invest 41: 1863–1870

    CAS  Article  Google Scholar 

  33. 33

    Ball GV and Morgan JM (1968) Chronic lead ingestion and gout. South Med J 61: 21–24

    Article  Google Scholar 

  34. 34

    Ralston SH et al. (1988) Alcohol and response to treatment of gout. BMJ 296: 1641–1642

    CAS  Article  Google Scholar 

  35. 35

    Choi HK et al. (2005) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 165: 742–748

    Article  Google Scholar 

  36. 36

    Messerli FH et al. (1980) Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 93: 817–821

    CAS  Article  Google Scholar 

  37. 37

    Tykarski A (1991) Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 59: 364–368

    CAS  Article  Google Scholar 

  38. 38

    Friedl HP et al. (1991) Role of oxygen radicals in tourniquet-related ischemia-reperfusion injury of human patients. Klin Wochenschr 69: 1109–1112

    CAS  Article  Google Scholar 

  39. 39

    Ter Maaten JC et al. (1997) Renal handling of urate and sodium during acute physiological hyperinsulinaemia in healthy subjects. Clin Sci (Lond) 92: 51–58

    CAS  Article  Google Scholar 

  40. 40

    Enomoto A et al. (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417: 447–452

    CAS  Article  Google Scholar 

  41. 41

    Simkin PA (1977) The pathogenesis of podagra. Ann Intern Med 86: 230–233

    CAS  Article  Google Scholar 

  42. 42

    Fam AG et al. (1996) Gouty arthritis in nodal osteoarthritis. J Rheumatol 23: 684–689

    CAS  PubMed  Google Scholar 

  43. 43

    Kawenoki-Minc E et al. (1974) Osteoarthrosis and spondylosis in gouty patients. Analysis of 262 cases of gout [Polish]. Reumatologia 12: 267

    CAS  PubMed  Google Scholar 

  44. 44

    Wilcox WR and Khalaf AA (1975) Nucleation of monosodium urate crystals. Ann Rheum Dis 34: 332–339

    CAS  Article  Google Scholar 

  45. 45

    Perricone E and Brandt KD (1978) Enhancement of urate solubility by connective tissue. I. Effect of proteoglycan aggregates and buffer cation. Arthritis Rheum 21: 453–460

    CAS  Article  Google Scholar 

  46. 46

    Ford ES et al. (2004) Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27: 2444–2449

    Article  Google Scholar 

  47. 47

    Gu Q et al. (2006) Antihypertensive medication use among US adults with hypertension. Circulation 113: 213–221

    CAS  Article  Google Scholar 

  48. 48

    Academy of Medical Sciences (2004) Calling time: the nation's drinking as a major health issue. London: Academy of Medical Sciences

  49. 49

    Lysaght MJ (2002) Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 13 (Suppl 1): S37–S40

    PubMed  Google Scholar 

  50. 50

    Pal B et al. (2000) How is gout managed in primary care? A review of current practice and proposed guidelines. Clin Rheumatol 19: 21–25

    CAS  Article  Google Scholar 

Download references


We are grateful for funding from the Arthritis Research Campaign, UK.

Author information



Corresponding author

Correspondence to Edward Roddy.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Roddy, E., Zhang, W. & Doherty, M. The changing epidemiology of gout. Nat Rev Rheumatol 3, 443–449 (2007).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing